RecombinantFGF-9, Human
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


RecombinantFGF-9, Human
Description:
Fibroblast Growth Factor-9 (FGF-9) is a heparin binding growth factor that belongs to the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. FGF-9 was isolated as a secreted factor that exhibits a growth-stimulating effect on cultured glial cells. In nervous system, this protein is produced mainly by neurons and may be important for glial cell development.Recombinant Human Fibroblast Growth Factor-9 (rhFGF-9) produced in E.coli is a single non-glycosylated polypeptide chain containing 208 amino acids. A fully biologically active molecule, rhFGF-9 has a molecular mass of 23.4 kDa analyzed by reducing SDS-PAGE and is obtained by proprietary chromatographic techniques at GenScript.Endotoxin:
< 0.2 EU/μg, determined by LAL method.Purity:
> 95% by SDS-PAGE and HPLC analyses.Bioactivity:
ED50 < 2.0 ng/ml , measured by a cell proliferation assay using 3T3 cells, corresponding to a specific activity of >5.0x 10ˆ5 units/mg.Reconstitution:
Reconstituted in ddH2O at 100 μg/ml.Molecular Weight:
23.4 kDa, observed by reducing SDS-PAGE.Storage Conditions:
Lyophilized recombinant Human Fibroblast Growth Factor-9 (rhFGF-9) remains stable up to 6 months at -80°C from date of receipt. Upon reconstitution, rhFGF-9 should be stable up to 2 weeks at 4°C or up to 3 months at -20°C.Appearance:
Sterile Filtered White lyophilized (freeze-dried) powder.Formulation:
Lyophilized after extensive dialysis against PBS.Host or Source:
Escherichia coli.Recommended Usage:
This material is offered by USA Bioworld biotech for research, laboratory or further evaluation purposes. For research use only.CAS Number:
9000-83-3AA Sequence:
MAPLGEVGN YFGVQDAVPF GNVPVLPVDS PVLLSDHLGQ SEAGGLPRGP AVTDLDHLKG ILRRRQLYCR TGFHLEIFPN GTIQGTRKDH SRFGILEFIS IAVGLVSIRG VDSGLYLGMN EKGELYGSEK LTQECVFREQ FEENWYNTYS SNLYKHVDTG RRYYVALNKD GTPREGTRTK RHQKFTHFLP RPVDPDKVPE LYKDILSQS
